Hoffmann-La Roche Buys DeCypher Accelerator For Drug Discovery | GenomeWeb

INCLINE VILLAGE, Nev.--Time Logic here has sold a DeCypher ES-1920 computational bioinformatics accelerator to Hoffmann-La Roche, which "intends to use this powerful computer tool in the process of the discovery of new drugs to treat human diseases and conditions," according to the pharmaceutical company's Michael Braxenthaler. DeCypher uses unique search algorithms, accelerated to supercomputing speeds by an array of parallel processors, to rapidly search large DNA and protein sequence databases, according to Richard Offerdahl, the company's president and CEO.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.